SEC Form D filing

Solve Therapeutics, Inc., 2025-11-25

An SEC Form D private-offering notice from Belmont, CA, a $120,535,618 filer-stated offering target in Biotech. Filed 2025-11-25. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Solve Therapeutics, Inc. site↗ Verified via SEC Form D

Develops antibody-drug conjugates and bispecific therapeutics for solid tumor oncology using proprietary linker technology.

Filed 2025-11-25Filed to raise $120,535,618First money in 2025-11-14Raised so far $48,214,232HQ (as filed) Belmont, CASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified solvetx.com↗Named in the filing 8 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source